Compare Pinterest Inc (PINS) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pinterest Inc vs Tango Therapeutics Inc. — how do they compare? Pinterest Inc trades at $21.75 (market cap $12.67B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Pinterest Inc is far larger — about 3.4× Tango Therapeutics Inc.'s market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and Tango Therapeutics Inc. for 0 Days on average.
| PINS | TNGX | |
|---|---|---|
Market Cap | $12.67B | $3.75B |
Volume | 12,391,118 | 9,619,106 |
Sector | Media | Health |
52-Week High | $35.24 | $32.90 |
52-Week Low | $15.42 | $7.50 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $12.59B | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $21.76, up 1.56% today, with a bullish technical signal from moving averages and strong recent earnings beats. Revenue has grown from $2.8B in 2022 to $4.2B in 2025, though net income margin is modest at 5.46%. The company continues to innovate with new ad products like Visual Search Ads, enhancing its advertising moat. Analyst consensus is bullish with a $27.93 price target, but high valuation ratios and insider selling present cautionary notes.
The outlook for PINS is positive given consistent revenue growth and strategic ad initiatives, offering potential upside to the consensus target. However, risks include elevated P/E of 65.79, competitive pressures in social media advertising, and negative net cash flow trends. Investors should weigh strong fundamentals against valuation concerns and market volatility.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
